Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1269)
INSMED Inc (INSM)
Lewis William — Director
Shares
1,629
Price
$142.17
Total Value
$231.59K
Shares Held After
310,255
% of Holdings
0.5%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
39,000
Price
$2.50
Total Value
$97.50K
Shares Held After
0
% of Holdings
100.0%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
1,163
Price
$97.44
Total Value
$113.32K
Shares Held After
58,518
% of Holdings
1.9%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
11,964
Price
$67.00
Total Value
$801.59K
Shares Held After
33,421
% of Holdings
26.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Shares
2,186
Price
$67.00
Total Value
$146.46K
Shares Held After
43,316
% of Holdings
4.8%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
4,589
Price
$67.00
Total Value
$307.46K
Shares Held After
85,780
% of Holdings
5.1%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
390
Price
$67.00
Total Value
$26.13K
Shares Held After
23,308
% of Holdings
1.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
4,174
Price
$67.00
Total Value
$279.66K
Shares Held After
35,028
% of Holdings
10.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Mottiwala Aziz — Chief Commercial Officer
Shares
4,440
Price
$67.00
Total Value
$297.48K
Shares Held After
61,480
% of Holdings
6.7%
Tarsus Pharmaceuticals, Inc. (TARS)
Wahl Bryan — General Counsel
Shares
4,231
Price
$67.00
Total Value
$283.48K
Shares Held After
63,959
% of Holdings
6.2%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
1,461
Price
$29.99
Total Value
$43.82K
Shares Held After
40,702
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
80
Price
$533.41
Total Value
$42.67K
Shares Held After
45,172
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
650
Price
$532.50
Total Value
$346.12K
Shares Held After
45,252
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
794
Price
$531.62
Total Value
$422.11K
Shares Held After
45,902
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,776
Price
$530.63
Total Value
$942.41K
Shares Held After
46,696
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,808
Price
$529.82
Total Value
$1.49M
Shares Held After
48,472
% of Holdings
5.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,439
Price
$528.41
Total Value
$760.38K
Shares Held After
51,280
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
753
Price
$527.47
Total Value
$397.18K
Shares Held After
52,719
% of Holdings
1.4%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
6,499
Price
$18.84
Total Value
$122.41K
Shares Held After
339,392
% of Holdings
1.9%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,877
Price
$24.97
Total Value
$71.84K
Shares Held After
147,053
% of Holdings
1.9%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
304
Price
$119.08
Total Value
$36.20K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,730
Price
$118.37
Total Value
$204.78K
Shares Held After
304
% of Holdings
85.1%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
2,268
Price
$117.56
Total Value
$266.63K
Shares Held After
2,034
% of Holdings
52.7%
ARVINAS, INC. (ARVN)
Berkowitz Noah — Chief Medical Officer
Shares
6,435
Price
$11.10
Total Value
$71.43K
Shares Held After
202,503
% of Holdings
3.1%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
11,667
Price
$68.71
Total Value
$801.64K
Shares Held After
45,385
% of Holdings
20.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Shares
2,133
Price
$68.71
Total Value
$146.56K
Shares Held After
45,502
% of Holdings
4.5%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
3,610
Price
$68.71
Total Value
$248.04K
Shares Held After
90,369
% of Holdings
3.8%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
379
Price
$68.71
Total Value
$26.04K
Shares Held After
23,698
% of Holdings
1.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
4,071
Price
$68.71
Total Value
$279.72K
Shares Held After
39,202
% of Holdings
9.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Mottiwala Aziz — Chief Commercial Officer
Shares
4,330
Price
$68.71
Total Value
$297.51K
Shares Held After
65,920
% of Holdings
6.2%
Tarsus Pharmaceuticals, Inc. (TARS)
Wahl Bryan — General Counsel
Shares
4,125
Price
$68.71
Total Value
$283.43K
Shares Held After
68,190
% of Holdings
5.7%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
72
Price
$32.85
Total Value
$2.37K
Shares Held After
28,836
% of Holdings
0.2%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
334
Price
$31.79
Total Value
$10.62K
Shares Held After
28,908
% of Holdings
1.1%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
4,222
Price
$31.28
Total Value
$132.08K
Shares Held After
29,242
% of Holdings
12.6%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
30
Price
$32.85
Total Value
$985.50
Shares Held After
10,276
% of Holdings
0.3%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
139
Price
$31.79
Total Value
$4.42K
Shares Held After
10,306
% of Holdings
1.3%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
1,762
Price
$31.28
Total Value
$55.12K
Shares Held After
10,445
% of Holdings
14.4%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
37
Price
$32.85
Total Value
$1.22K
Shares Held After
10,172
% of Holdings
0.4%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
172
Price
$31.79
Total Value
$5.47K
Shares Held After
10,209
% of Holdings
1.7%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
2,173
Price
$31.28
Total Value
$67.98K
Shares Held After
10,381
% of Holdings
17.3%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
103
Price
$32.85
Total Value
$3.38K
Shares Held After
40,798
% of Holdings
0.3%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
483
Price
$31.79
Total Value
$15.35K
Shares Held After
40,901
% of Holdings
1.2%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
6,100
Price
$31.28
Total Value
$190.83K
Shares Held After
41,384
% of Holdings
12.8%
Aldeyra Therapeutics, Inc. (ALDX)
Alfieri Michael — Principal Financial Officer
Shares
5,000
Price
$1.42
Total Value
$7.10K
Shares Held After
7,500
% of Holdings
66.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$539.99
Total Value
$86.40K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$537.66
Total Value
$21.51K
Shares Held After
40,673
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
419
Price
$531.71
Total Value
$222.79K
Shares Held After
40,713
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,739
Price
$530.94
Total Value
$1.45M
Shares Held After
41,132
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,558
Price
$530.09
Total Value
$1.36M
Shares Held After
43,871
% of Holdings
5.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,064
Price
$529.05
Total Value
$562.91K
Shares Held After
46,429
% of Holdings
2.2%
Showing 101–150 of 1269 transactions (page 3 of 26)